CA2071896A1 - Inhibitor of lymphocyte response and immune-related disease - Google Patents

Inhibitor of lymphocyte response and immune-related disease

Info

Publication number
CA2071896A1
CA2071896A1 CA002071896A CA2071896A CA2071896A1 CA 2071896 A1 CA2071896 A1 CA 2071896A1 CA 002071896 A CA002071896 A CA 002071896A CA 2071896 A CA2071896 A CA 2071896A CA 2071896 A1 CA2071896 A1 CA 2071896A1
Authority
CA
Canada
Prior art keywords
peptide
amino acid
peptides
arthritis
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002071896A
Other languages
English (en)
French (fr)
Inventor
Willem Van Eden
Marca H. M. Wauben
Ruurd Van Der Zee
Claire J. P. Boog
Irun R. Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Nederlanden Staat
Universiteit Utrecht
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2071896A1 publication Critical patent/CA2071896A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002071896A 1990-09-06 1991-09-05 Inhibitor of lymphocyte response and immune-related disease Abandoned CA2071896A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57850690A 1990-09-06 1990-09-06
US578,506 1990-09-06

Publications (1)

Publication Number Publication Date
CA2071896A1 true CA2071896A1 (en) 1992-03-07

Family

ID=24313172

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002071896A Abandoned CA2071896A1 (en) 1990-09-06 1991-09-05 Inhibitor of lymphocyte response and immune-related disease

Country Status (8)

Country Link
EP (1) EP0503055A1 (enrdf_load_stackoverflow)
JP (1) JPH05507501A (enrdf_load_stackoverflow)
AU (1) AU650065B2 (enrdf_load_stackoverflow)
CA (1) CA2071896A1 (enrdf_load_stackoverflow)
IL (1) IL99429A0 (enrdf_load_stackoverflow)
NZ (1) NZ239699A (enrdf_load_stackoverflow)
WO (1) WO1992004049A1 (enrdf_load_stackoverflow)
ZA (1) ZA917097B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027634A1 (en) * 1993-06-02 1994-12-08 Institute For Child Health Research Cryptic peptides for use in inducing immunologic tolerance
DK0751957T3 (da) * 1994-03-21 2004-06-01 Univ Utrecht Peptid-fragmenter af mikrobielle stressproteiner og farmaceutisk sammensætning fremstillet deraf til behandling og forebyggelse af inflammatoriske sygdomme
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
IT1271074B (it) * 1994-11-21 1997-05-26 Italfarmaco Spa Peptidi ad attivita' antiinfiammatoria
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
JP2001511134A (ja) * 1997-01-24 2001-08-07 オートイミューン インク メトトレキサートと組合せる耐性化を用いる自己免疫疾患の治療
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
ES2526822T3 (es) 2002-01-31 2015-01-15 Andromeda Bio Tech Ltd. Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno
AU2003230181A1 (en) 2002-05-21 2003-12-02 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation

Also Published As

Publication number Publication date
JPH05507501A (ja) 1993-10-28
ZA917097B (en) 1992-09-30
WO1992004049A1 (en) 1992-03-19
AU650065B2 (en) 1994-06-09
AU8755991A (en) 1992-03-30
EP0503055A4 (enrdf_load_stackoverflow) 1994-02-16
EP0503055A1 (en) 1992-09-16
IL99429A0 (en) 1992-08-18
NZ239699A (en) 1993-11-25

Similar Documents

Publication Publication Date Title
Anderton et al. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis.
JP2635444B2 (ja) 自己抗体の経口投与による自己免疫性疾患の治療
EP0359783B1 (en) Treatment of autoimmune diseases by oral administration of autoantigens
Sakai et al. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
US5869054A (en) Treatment of multiple sclerosis by oral administration of autoantigens
Hu et al. Experimental mucosal induction of uveitis with the 60‐kDa heat shock protein‐derived peptide 336–351
Wraith et al. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity.
Racke et al. Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation
AU650065B2 (en) Inhibitor of lymphocyte response and immune-related disease
Fujii et al. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
Ragno et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis
US6541453B2 (en) Peptide derivatives
MXPA06010364A (es) Identificacion de antigenos puros y no puros implicados en enfermedades autoinmunes.
Steinman The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease
US20020058787A1 (en) Mhc binding peptide oligomers and methods of use
Yang et al. Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein
RU2127599C1 (ru) Композиция для профилактики и лечения спида, или системной красной волчанки, или связанных с ними нарушений
HU224160B1 (hu) P277 Peptidanalógok, ezek alkalmazása a diabétesz in vitro diagnosztizálására szolgáló gyógyszerkészítmények előállítására, gyógyszerkészítmények és diagnosztikus kit
MXPA04007510A (es) Peptidos tolerogenicos de la proteina basica de mielina.
AU722877C (en) Peptide derivatives
Vandenbark et al. Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats.
CA2200338A1 (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
JPH11507354A (ja) 自己免疫疾患処置のためのｍｈｃクラスｉｉ分子のペプチドを用いるワクチン接種
US6355617B1 (en) Peptide derivatives
HU200479B (en) Process for producing peptides having immunosuppressive activity and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
FZDE Discontinued